1. Home
  2. HIO vs AURA Comparison

HIO vs AURA Comparison

Compare HIO & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset High Income Opportunity Fund Inc.

HIO

Western Asset High Income Opportunity Fund Inc.

HOLD

Current Price

$3.64

Market Cap

364.2M

Sector

Finance

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.72

Market Cap

377.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIO
AURA
Founded
1993
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
364.2M
377.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HIO
AURA
Price
$3.64
$6.72
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$19.00
AVG Volume (30 Days)
398.9K
251.4K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
10.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.36
$4.73
52 Week High
$4.05
$7.48

Technical Indicators

Market Signals
Indicator
HIO
AURA
Relative Strength Index (RSI) 45.60 62.04
Support Level N/A $5.83
Resistance Level $3.89 $6.73
Average True Range (ATR) 0.05 0.40
MACD -0.00 0.01
Stochastic Oscillator 59.11 73.03

Price Performance

Historical Comparison
HIO
AURA

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: